In a recent study, we found that TNF-␣ negatively regulates airway responsiveness through the activation of ␥␦ T cells. The biological activities of TNF-␣ are mediated by two structurally related but functionally distinct receptors, p55 (TNFR1) and p75 (TNFR2), which are independently expressed on the cell surface. However, the relative importance of either TNFR in airway hyperresponsiveness (AHR) is unknown. To investigate the importance of these TNFRs in the development of allergen-induced AHR, p55-deficient and p75-deficient mice were sensitized to OVA by i.p. injection and subsequently challenged with OVA via the airways; airway responsiveness to inhaled methacholine was monitored. p75-deficient mice developed AHR to a similar degree as control mice. In contrast, p55-deficient mice, which were sensitized and challenged with OVA, failed to develop AHR. In p55deficient mice, both the numbers of eosinophils and levels of IL-5 in bronchoalveolar lavage fluid were significantly lower than in sensitized/challenged control mice (p < 0.05). However, depletion of ␥␦ T cells resulted in significant increases in AHR in the p55-deficient mice, whereas no significant effect of ␥␦ T cell depletion was evident in the p75-deficient mice. These data indicate that, in the absence of TNFR1 (p55), where TNF-␣ uses the p75 pathway exclusively, the development of AHR is regulated by ␥␦ T cells.
T umor necrosis factor-␣ is identified as an important mediator of early T cell activation and of differential proliferative responses. The biological activities of TNF-␣ are mediated by two structurally related but functionally distinct receptors, p55 (TNFR1) and p75 (TNFR2), which are independently expressed on the cell surface (1, 2) . Some studies indicate that the p55 receptor is the primary signaling receptor on most cell types through which the majority of inflammatory responses classically attributed to TNF-␣ are mediated. In contrast, TNF-␣-induced thymocyte proliferation, TNF-␣-mediated skin necrosis, and apoptosis of activated, mature T lymphocytes are mediated through the p75 receptor (3) (4) (5) . Specifically, animals lacking the p55 receptor do not develop inflammatory reactions in response to TNF-␣, whereas animals lacking p75 receptor remain responsive (6, 7) . Human airway tissue expresses both types of TNFRs (8) , but their functional importance is only just emerging. Activation through p55 results in proliferation of human tracheal smooth muscle cells; in contrast, specific stimulation of the p75 receptor with recombinant TNF-␣ did not induce these effects (9) .
In a recent study we found that ␥␦ T cells down-regulate airway hyperresponsiveness (AHR) 3 in a mouse model of airway inflam-mation and hyperresponsiveness (10) . We also reported that TNF-␣ negatively regulates airway responsiveness through ␥␦ T cells (11) . In an earlier study we found that ␥␦ T cells respond more strongly to TNF-␣ than do ␣␤ T cells (12) . The stronger response of ␥␦ T cells to TNF-␣ was correlated with higher levels of the inducible expression of the p75 receptor (12) . However, the relative importance of either of the TNF-␣ receptors in AHR and airway inflammation, characterized by an influx of activated eosinophils and T lymphocytes (13) (14) (15) , is to a large extent unknown.
To clarify the significance of the two TNFRs in the development of allergen-induced AHR, TNFR p55-deficient and p75-deficient mice were sensitized to OVA by i.p. injection and subsequently challenged with OVA via the airways. We monitored airway responses to inhaled methacholine (MCh) and inflammatory cell infiltration in the airways and also investigated the consequences of depletion of ␥␦ T cells on these responses. The results revealed distinct functions of these two receptors on the development of these responses as well as their influence on ␥␦ T cell function.
Materials and Methods

Animals
Female C57BL/6 mice from 8 to 10 wk of age were purchased from The Jackson Laboratory (Bar Harbor, ME). Mice genetically deficient for TNFR p55 and TNFR p75 (16) (back-crossed onto the C57BL/6 genetic background) from 8 to 10 wk of age were a gift from Dr. D. Lynch (Immunex, Seattle, WA). The mice were maintained on OVA-free diets. All experimental animals used in this study were under a protocol approved by the Institutional Animal Care and Use Committee of the National Jewish Medical and Research Center. challenged via the airways to OVA (1% in saline) for 20 min on days 28, 29, and 30 by ultrasonic nebulization (De Vilbiss; particle size 1-5 m). Lung resistance (RL) and dynamic compliance (Cdyn) were assessed 48 h after the last allergen challenge, and the mice were sacrificed to obtain tissues and cells for further assays.
Determination of airway responsiveness to inhaled MCh
RL and Cdyn were determined as a change in airway function after aerosolized MCh challenge. Anesthetized, tracheostomized mice were mechanically ventilated and lung function was assessed as described (17) . Aerosolized MCh was administered for 10 breaths at a rate of 60 breaths/min, tidal volume of 500 l by the ventilator (model 683; Harvard Apparatus, South Natick, MA) in increasing concentrations (6.25, 12.5, 25, 50 , and 100 mg/ml). After each MCh challenge, the data were continuously collected for 1-5 min and maximum values of RL and minimum values of Cdyn were taken to express changes in these functional parameters.
Determination of cell numbers and cytokine levels in bronchoalveolar lavage fluid (BALF)
Immediately after assessment of RL and Cdyn, lungs were lavaged via the tracheal tube with HBSS (1 ϫ 1 ml at 37°C). The volume of collected BALF was measured in each sample and the number of bronchoalveolar lavage cells was counted by cell counter (Coulter Counter; Coulter, Hialeah, FL). Cytospin slides were stained with Leukostat (Fisher Diagnostics, Pittsburgh, PA) and differential cell counts were performed in a blinded fashion, counting at least 300 cells under light microscopy.
Cytokine (IL-4, IL-5, and IFN-␥) levels in BALF supernatants were measured by ELISAs as described (18) and IL-10, IL-12 (p70), and IL-13 were assayed by ELISA (R&D Systems, Minneapolis, MN) according to the manufacturer's recommendations. Cytokine levels were determined by comparison with known standards. The limit of detection was 4 pg/ml.
Measurement of serum anti-OVA Ab and total Ig levels
Anti-OVA IgE Ab levels were measured by ELISA, as previously described (19) , 48 h after the last airway challenge. The Ab titers of the samples were related to pooled standards that were generated in the laboratory and expressed as ELISA units per milliliter. Total IgE levels were determined using the same method compared with a known mouse IgE standard (BD PharMingen, San Diego, CA). The limit of detection was 100 pg/ml for IgE.
Abs and ␥␦ T cell depletion
Monoclonal anti-murine TCR-␤ Ab (H57-597) was described previously (20) . Monoclonal anti-murine TCR-␦ Abs (GL3 and 403A10) that were panspecific for TCR-␦ were gifts from Drs. L. LeFrançois (University of Connecticut, Farmington, CT) (21) and S. Tonegawa (Massachusetts Institute of Technology, Cambridge, MA) (22) . The dose administered was optimized for depletion and routinely depleted Ͼ90% of splenic and pulmonary ␥␦ T cells (10) . mAbs were prepared from Ab-secreting hybridoma cell lines. These mAbs were purified on affinity columns and quantified.
Depletion was achieved after injection of 200 g hamster IgG mAb anti-TCR-␦ (1:1 mixture of GL3 and 403A10) into the tail vein 3 days before the first OVA challenge (21) . Sham depletion was conducted using hamster IgG (The Jackson Laboratory).
T cell purification and FACS analysis
Lung cells were isolated as previously described (23) and passed through nylon wool columns to yield an enriched T cell preparation containing Ͼ90% CD3 ϩ cells as previously described (24) .
For cytofluorographic analysis, mAbs were conjugated with N-hydroxysuccinimido-biotin (Sigma-Aldrich) and/or FITC isomer I on Celite (Sigma-Aldrich) and analyzed on an XL2 cytofluorograph (Coulter, Miami, FL). Streptavidin-PE (diluted at 1/100 per 1 ϫ 10 6 cells; BioSource International, Camarillo, CA) was used for the biotin-conjugated Abs to enhance detection as described (25) .
Histologic and immunohistochemistry studies
After obtaining the BALF, lungs were inflated through the tracheal tube with 2 ml air and fixed in 10% formalin. Portions of lung tissue were cut around the main bronchus and embedded in paraffin blocks. Tissue sections (5 m thick) were cut, deparaffinized, and then stained with H&E and examined under light microscopy. The examiner was blinded as to treatment group.
Cells containing major basic protein (MBP) in lung sections were identified by immunohistochemical staining and quantitated as described using a rabbit anti-mouse MBP (provided by Dr. J. J. Lee, Mayo Clinic, Scottsdale, AZ) (23).
Statistical analysis
Values for all measurements were expressed as the mean Ϯ SEM. Student's two-tailed unpaired t test was used to determine the levels of difference between two experimental groups. ANOVA was used to compare percentage changes of RL and Cdyn between different groups with the same treatment. The values for significance were set at p Ͻ 0.05.
Results
p55-deficient mice fail to develop AHR
TNF-␣ exerts its activities by interacting with two functionally distinct receptors, p55 and p75, which are independently expressed on the cell surface. To determine the importance of TNF-␣ receptors in the development of allergen-induced AHR, we monitored airway responsiveness to inhaled MCh in p55-deficient and p75deficient mice. There was no significant difference in RL and Cdyn between C57BL/6 (wild-type (WT)) mice and p55-and p75deficient mice exposed to OVA alone (challenge alone) ( Fig. 1 ). After OVA sensitization and challenge, p55-deficient mice failed to develop AHR, whereas p75-deficient mice developed AHR similar to WT C57BL/6 mice ( Fig. 1 ). These results indicate that the TNFRs p55 and p75 play different roles in the development of allergen-induced AHR.
Inflammatory cell accumulation in the airways of TNFR-deficient mice
The number and types of inflammatory cells in the airways of TNFR-deficient mice were measured in BALF. In mice that underwent OVA challenge alone, very few inflammatory cells were detected ( Fig. 2A ). Sensitization and challenge with OVA resulted in a marked increase in the number of eosinophils in the BALF, although the number of eosinophils in the p75-deficient mice and especially p55-deficient mice were significantly lower than in WT mice. Nonsensitized but OVA-challenged p75-deficient mice had an increased number of lymphocytes in BALF compared with p55deficient and WT mice ( Fig. 2A ).
Examination of lung tissue showed that, in mice that underwent challenge alone, very little inflammatory cell infiltration was detected, whereas OVA sensitization and challenge via the airways increased the number of eosinophils and lymphocytes at these sites. Eosinophils in the lung tissue were identified by immunohistochemical staining and quantitated as described using a rabbit anti-mouse MBP. Eosinophil numbers in the peribronchial, perivascular, and peripheral airways of p55-deficient mice were significantly lower than those in WT or p75-deficient mice after OVA sensitization and challenge ( Fig. 2B ).
Cytokine levels in p55-deficient and p75-deficient mice
Concentrations of inflammatory cytokines in BALF supernatants were measured by ELISA. After OVA sensitization and challenge, IL-4, IL-5, IL-10, and IL-13 levels in BALF increased significantly compared with mice challenged alone in all three groups of mice. IL-4 levels were not significantly different in p55-or p75-deficient mice or WT controls (Fig. 3A) . IL-5 levels in p55-deficient mice were significantly lower than in the WT controls and p75-deficient mice (Fig. 3B ). IL-10 levels increased similarly in all three groups after sensitization and challenge ( Fig. 3C ) and IL-13 levels paralleled those of IL-5, with the p55-deficient mice showing the smallest increase ( Fig. 3E ). For each group, OVA sensitization and challenge also resulted in an increase in IL-12 ( Fig. 3D ) and IFN-␥ ( Fig. 3F ) levels compared with animals challenged alone, but both IFN-␥ and IL-12 levels were lower in the p55deficient than in the WT or p75-deficient mice. These results indicate that the absence of the p55 receptor impacts the levels of both Th1 and Th2 cytokines.
Serum anti-OVA IgE Ab levels
Anti-OVA IgE Ab levels were measured by ELISA 48 h after the last airway challenge. Anti-OVA IgE and total IgE levels in the serum of OVA-sensitized and -challenged WT mice, p55-and p75deficient mice were not significantly different from one another (Table I) .
␣␤ T cells and ␥␦ T cells in TNFR-deficient mice
The numbers of ␣␤ T cells and ␥␦ T cells in the lungs were analyzed ( Fig. 4 ). Numbers of nylon wool nonadherent ␣␤ T cells in the lungs of p55-deficient mice were significantly lower when compared with WT and p75-deficient mice. The number of ␥␦ T cells in the lungs of TNFR p75-deficient mice was significantly increased compared with the other mice. Treatment with anti-TCR-␦ mAb not only decreased the numbers of ␥␦ T cells in all groups of mice but also resulted in increased numbers of ␣␤ T cells in sensitized and challenged p75-deficient mice.
␥␦ T cell depletion restores airway responsiveness in p55-deficient mice
We previously demonstrated that ␥␦ T cells play a negative regulatory role in the development of AHR (10) and that TNF-␣ negatively regulated AHR through ␥␦ T cells (11) . Therefore, we examined whether ␥␦ T cells play a role in the failure of p55-deficient mice to develop AHR. As shown in Fig. 4 , anti-␦ treatment effectively eliminated ␥␦ T cells in all three groups of mice. WT mice showed an increase in AHR after ␥␦ T cell depletion, confirming previous results (10) (Fig. 5 ). p55-deficient mice treated with anti-TCR-␦ developed significant AHR after OVA sensitization and challenge; the levels were similar to untreated WT mice. In contrast, p75deficient mice administered anti-TCR-␦ failed to show any differences in the level of AHR compared with nontreated mice.
Effect of anti-TCR-␦ treatment on AHR was not associated with changes in cellular inflammatory response
In anti-TCR-␦-treated, OVA-sensitized and -challenged p55-deficient mice, which now demonstrated AHR, there was no significant difference in the composition of inflammatory cells in BALF as a result of ␥␦ T cell depletion (Fig. 6 ). The lower number of eosinophils seen in p55-deficient mice after sensitization and challenge ( Fig. 2 ) was still evident (and even lower) after ␥␦ T cell depletion, despite the development of AHR.
Discussion
The relative importance of the individual TNFRs, p55 (TNFR1) and p75 (TNFR2), in mediating the actions of TNF-␣ is not well defined (3) (4) (5) (6) (7) . In this paper we demonstrate that OVA-sensitized and -challenged p75-deficient mice developed AHR to a similar degree as WT mice but p55-deficient mice failed to develop AHR. Such data confirm that the two TNFRs play distinct roles in the development of AHR, and this may be the result of the induction of different airway inflammatory pathways. The data indicate that eosinophil numbers in BALF in both the p55-and p75-deficient mice after OVA sensitization and challenge were lower than in WT mice, but the number of eosinophils in p55-deficient mice was even further decreased compared with p75-deficient mice. The p55 receptor appears to play an important role in the up-regulation of endothelial cell adhesion molecule expression at the sites of allergen challenge, as evidenced by studies demonstrating reduced eosinophil rolling and adhesion and accumulation in the BALF in allergen-challenged p55-and p55/p75-deficient mice (26) . In p55deficient mice, the levels of both IL-5 and IL-13 in BALF were significantly lower compared with sensitized and challenged WT mice and p75-deficient mice; in p75-deficient mice there were no significant differences compared with WT mice. Moreover, both IFN-␥ and IL-12 levels in the p55-deficient mice after sensitization and challenge were significantly lower than those in controls, and IL-4 and IL-10 levels in both p55-deficient mice and p75-deficient mice were not significantly different from WT mice. These results and the failure to develop AHR in sensitized and challenged p55deficient mice indicate that TNFR1 plays an important role in regulating Ag-induced Th2 cytokine production (IL-5 and IL-13), Th1 cytokine production (IFN-␥ and IL-12), eosinophil and lymphocyte recruitment to the lung, and airway function. In the absence of the p75 receptor there appeared to be fewer consequences.
Independent expression on cells (27, 28) , DNA analysis (1, 2, 29), and lack of homology of the intracellular domains (30) suggest that the two receptors should be responsible for inducing divergent cellular responses. TNFR p75 exhibits greater specificity and higher affinity in its interactions with TNF-␣ than does the p55 receptor (31) . It has been proposed that, at low concentrations of TNF, p75 functions as a catcher by binding TNF and delivering it to the p55 receptor (32) . Unlike p55, p75 seems to function in transmitting activating signals for apoptosis (31) (32) (33) (34) . The murine p55 receptor binds both murine and human TNF-␣ while the murine p75 receptor binds only its homologous murine ligand and not the human protein (35, 36) . Furthermore, recent experiments using p55-deficient mice have demonstrated that the p55 TNFR plays a physiologically important role in promoting lethal shock induced by LPS and galactosamine and in effecting antimicrobial responses to Listeria monocytogenes (7, 37) . By comparison, little information is available concerning the biologic responses mediated by the p75 TNFR. In vivo experiments have suggested that the p75 receptor enhances p55-induced biologic responses by facilitating binding to p55 (38) . In addition, p75 induces proliferative responsiveness in certain cells of hematopoietic origin and enhances expression of certain adhesion molecules such as ICAM-1 (4, 32) . The underlying mechanisms are not known, but growing evidence now suggests that most of the biologic effects TNF-␣ exerts on airway smooth muscle are mediated by the p55 receptor (9) .
␥␦ T cells in mice and humans respond more strongly to TNF-␣ than do ␣␤ T cells (12) . The stronger response of ␥␦ T cells to TNF-␣ depends on the presence of p75 and is correlated with higher inducible expression levels of TNFR p75 in these cells (12) . Although ␣␤ T cells in allergic inflammation are essential contributors to increased AHR (10), we have found that ␥␦ T cells can exhibit negative regulatory effects on AHR, and we proposed that ␥␦ T cells exhibit different responses in the lung depending on the type of stimulus (10) . In this study, we investigated the numbers of ␣␤ T cells and ␥␦ T cells in the lungs of p55-and p75-deficient mice. Numbers of ␣␤ T cells in the lungs of p55-deficient mice were significantly lower when compared with those in the lungs of WT or p75-deficient mice. It thus appears that the p55 pathway is also central in the normal development of the allergic ␣␤ T cell response. In contrast, numbers of ␥␦ T cells in the lungs of p75deficient mice were significantly increased as compared with those FIGURE 2. Cellular composition of BALF (A) and tissue (B) in p55and p75-deficient mice. A, After OVA sensitization and challenge, eosinophil numbers in both p55-deficient and p75-deficient mice were significantly lower than those in C57BL/6 mice, and the number of eosinophils in p55-deficient mice was significantly lower compared with p75-deficient mice. B, Immunohistochemical localization of lung eosinophils. Lung tissue was stained with an Ab to MBP. The number of eosinophils (per square millimeter) in the peribronchial, perivascular, and peripheral airways was quantified as described in Materials and Methods. Eosinophil numbers in p55-deficient mice were significantly lower than those in C57BL/6 after OVA sensitization and challenge, and the number of eosinophils in p55-deficient mice was significantly lower compared with p75-deficient mice in the peribronchial and perivascular regions. p75-deficient mice (p75 Ϫ/Ϫ /N and p75 Ϫ/Ϫ /IPN) showed no significant difference when compared with C57BL/6 control mice (B6/N and B6/IPN, respectively). ‫,ء‬ Significant differences (p Ͻ 0.05) between OVA-challenged alone mice (B6/N, p55 Ϫ/Ϫ /N, p75 Ϫ/Ϫ /N) and OVAsensitized and -challenged mice (B6/IPN, p55 Ϫ/Ϫ /IPN, p75 Ϫ/Ϫ /IPN, respectively). ‫,ءء‬ Significant differences (p Ͻ 0.05) between OVA-sensitized and -challenged C57BL/6 mice (B6/IPN) and OVA-sensitized and -challenged p55-deficient mice (p55 Ϫ/Ϫ /IPN). ‫,ءءء‬ Significant differences (p Ͻ 0.05) between OVA-sensitized and -challenged C57BL/6 mice (B6/IPN) and OVA-sensitized and -challenged p75-deficient mice (p75 Ϫ/Ϫ /IPN). #, Significant differences (p Ͻ 0.05) between OVA-sensitized and -challenged p55-deficient mice (p55 Ϫ/Ϫ /IPN) and p75-deficient mice (p75 Ϫ/Ϫ /IPN). ##, Significant differences (p Ͻ 0.05) between nonsensitized p75-deficient mice (p75 Ϫ/Ϫ /N) and nonsensitized p55-deficient mice (p55 Ϫ/Ϫ /N) or C57BL/6 mice (B6/N). Results for each group are expressed as mean Ϯ SEM (n ϭ 8). Fig. 1 were measured in supernatants by ELISAs as described in Materials and Methods. p55-deficient mice had lower amounts of IL-5, IL-13, IFN-␥, and IL-12 in lavage fluid after OVA sensitization and challenge, whereas p75-deficient mice showed no significant levels compare to C57BL/6. ‫,ء‬ Significant differences (p Ͻ 0.05) between OVA-challenged alone mice (B6/N, p55 Ϫ/Ϫ /N, p75 Ϫ/Ϫ /N) and OVA-sensitized and -challenged mice (B6/IPN, p55 Ϫ/Ϫ /IPN, p75 Ϫ/Ϫ /IPN, respectively). ‫,ءء‬ Significant differences (p Ͻ 0.05) between OVA-sensitized and -challenged C57BL/6 mice (B6/IPN) and OVA-sensitized and -challenged p55-deficient mice (p55 Ϫ/Ϫ /IPN). ‫,ءءء‬ Significant differences (p Ͻ 0.05) between OVA-sensitized and -challenged C57BL/6 mice (B6/IPN) and OVA-sensitized and -challenged p75-deficient mice (p75 Ϫ/Ϫ /IPN). #, Significant differences (p Ͻ 0.05) between OVA-sensitized and -challenged p55-deficient mice (p55 Ϫ/Ϫ /IPN) and p75-deficient mice (p75 Ϫ/Ϫ /IPN). Results for each group are expressed as the mean Ϯ SEM (n ϭ 8).
in the lungs of WT (2.2-fold higher) or p55-deficient (3.2-fold higher) mice, implying that the p75 pathway is also responsible for negative regulatory effects of TNF-␣ on ␥␦ T cell expansion.
Consistent with our earlier studies (10, 11) , we found that depletion of ␥␦ T cells (by in vivo Ab treatment) resulted in increased AHR. This effect was most notable in the p55-deficient mice, where effects of TNF-␣ are exclusively mediated via the p75 pathway; increased AHR was also noted in the WT mice to a lesser extent (10, 11) . Presumably, TNF-␣ activated the ␥␦ T cells (12) , effectively preventing development of AHR, an effect independent of the inflammatory response. The absence of such an effect in p75-deficient mice further implies that the p75 pathway is required for the regulatory function of ␥␦ T cells. This same pathway also appears to shape the development of pulmonary ␥␦ T cells and their response to OVA, as indicated by the increase in ␥␦ T cells when it is absent. However, not all regulatory functions of ␥␦ T cells depend on TNF-␣ and the p75 pathway in particular. In vivo treatment with anti-TCR-␦ mAb showed that ␥␦ T cells can prevent or negatively impact the development of the allergic ␣␤ T cell response, and this effect was least prominent with the enlarged T cell population in the p75-deficient mice. Therefore, the p75 pathway not only may lead to activation of certain ␥␦ T cells but may Numbers of ␣␤ T cells in the lungs of p55-deficient mice were significantly lower when compared with C57BL/6 mice and p75-deficient mice. Numbers of ␥␦ T cells in the lungs of p75-deficient mice were significantly increased when compared with C57BL/6 mice and p55-deficient mice. Treatment with anti-TCR-␦ mAb significantly decreased the numbers of ␥␦ T cells in sensitized and challenged C57BL/6 mice and p55-deficient mice, and significantly increased the numbers of ␣␤ T cells and decreased the numbers of ␥␦ T cells in sensitized and challenged p75-deficient mice. ‫,ء‬ Significant differences (p Ͻ 0.05) between OVA-sensitized and -challenged C57BL/6 mice (B6ϩhamIgG) and p55-deficient mice (p55 Ϫ/Ϫ ϩhamIgG). ‫,ءء‬ Significant differences (p Ͻ 0.05) between OVA-sensitized and -challenged C57BL/6 mice (B6ϩhamIgG) and p75-deficient mice (p75 Ϫ/Ϫ ϩhamIgG). ‫,ءءء‬ Significant differences (p Ͻ 0.05) between OVA-sensitized and -challenged p55-deficient mice (p55 Ϫ/Ϫ ϩhamIgG) and p75-deficient mice (p75 Ϫ/Ϫ ϩhamIgG). #, Significant differences (p Ͻ 0.05) between sham-treated OVA-sensitized and -challenged mice (B6ϩhamIgG, p55 Ϫ/Ϫ ϩhamIgG, p75 Ϫ/Ϫ ϩhamIgG) and anti-TCR-␦-treated OVA-sensitized and -challenged mice (B6ϩanti-TCR-␦, p55 Ϫ/Ϫ ϩanti-TCR-␦, p75 Ϫ/Ϫ ϩanti-TCR-␦, respectively). Results for each group are expressed as the mean Ϯ SEM (n ϭ 4 -8). also hold in check, perhaps through induction of apoptosis, the expansion of these cells, as seen in the p75-deficient mice. In the p75-deficient mice, despite the increase in numbers of pulmonary ␥␦ T cells, their presence or depletion had little effect on development of AHR, consistent with a failure of their activation or differences in ␥␦ T cell subset distribution.
In summary, this study demonstrates complex contributions of the TNF-␣ receptors, p55 and p75, to the overall regulation of allergic inflammatory responses in the lung and the development of altered airway function. TNF-␣ interacts with ␥␦ T cells primarily through the p75 receptor pathway, and this interaction is associated with a down-regulation of AHR. In the absence of this pathway there is expansion of pulmonary ␥␦ T cells as well as normal development of AHR despite the increase in numbers. In contrast, the p55 receptor may be required for development of AHR and airway inflammation, and the interplay of both receptor-driven pathways shapes the allergic airway response and the mechanisms that control it. ‫,ء‬ Significant differences (p Ͻ 0.05) between hamster IgG-treated OVA-sensitized and -challenged p55-deficient mice (p55 Ϫ/Ϫ ϩhamIgG) and anti-TCR-␦-treated OVA-sensitized and -challenged p55-deficient mice (p55 Ϫ/Ϫ ϩanti-TCR-␦). #, Significant differences (p Ͻ 0.05) between shamtreated OVA-sensitized and -challenged C57BL/6 mice (B6ϩhamIgG) and anti-TCR-␦-treated OVA-sensitized and -challenged C57BL/6 mice (B6ϩanti-TCR-␦).
